AUSTIN, Texas, May 20, 2024 (GLOBE NEWSWIRE) — Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical stage biopharmaceutical company focused on therapeutics […]
Definitive agreement to acquire Spetner Associates marks significant milestone in Company’s evolution Expected to more than double current revenue to […]